UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs

Frontiers in microbiology, 2020-01, Vol.10, p.3060-3060

2020

Volltextzugriff (PDF)

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

The Journal of clinical investigation, 2021-12, Vol.131 (23)

2021

Volltextzugriff (PDF)

The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like

Frontiers in immunology, 2019, Vol.10, p.2251-2251

2019

Volltextzugriff (PDF)

Controlling SARS-CoV-2 in schools using repetitive testing strategies

eLife, 2022-07, Vol.11

2022

Volltextzugriff (PDF)

Virus-Specific T-Cell Therapy for Viral Infections of the Central Nervous System: A Review

Viruses, 2023-07, Vol.15 (7), p.1510

2023

Volltextzugriff (PDF)

Epigenetic control of HIV-1 post integration latency: implications for therapy

Clinical epigenetics, 2015-09, Vol.7 (1), p.103-103, Article 103

2015

Volltextzugriff (PDF)

Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study

International journal of infectious diseases, 2021-08, Vol.109, p.209-216

2021

Volltextzugriff (PDF)

CD32+CD4+ T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency

Cell reports (Cambridge), 2020-02, Vol.30 (7), p.2284-2296.e3

2020

Volltextzugriff (PDF)

Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies

Viruses, 2018-03, Vol.10 (4), p.157

2018

Volltextzugriff (PDF)

Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017

PloS one, 2021-11, Vol.16 (11), p.e0259073-e0259073

2021

Volltextzugriff (PDF)

Dynamics of Weight Change After Initiation of Contemporaneous Antiretroviral Therapy in Treatment-Naive HIV-1 Infected Patients: Results From the Belgian HIV Cohort 2015–2021

Journal of acquired immune deficiency syndromes (1999), 2023-06, Vol.93 (2), p.e4-e5

2023

Volltextzugriff (PDF)

Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs

Viruses, 2020-04, Vol.12 (5), p.489

2020

Volltextzugriff (PDF)

Dengue and chikungunya: future threats for Northern Europe?

Frontiers in Epidemiology (Online), 2024-01, Vol.4, p.1342723-1342723

2024

Volltextzugriff (PDF)

Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV

BMC infectious diseases, 2021-09, Vol.21 (1), p.1-910, Article 910

2021

Volltextzugriff (PDF)

Increased KL-6 levels in moderate to severe COVID-19 infection

PloS one, 2022-11, Vol.17 (11), p.e0273107

2022

Volltextzugriff (PDF)

Risk Factors for Late HIV Presentation in Patients Treated at a Single Belgian Reference Centre from 2018 to 2022

Infectious disease reports, 2024-03, Vol.16 (2), p.239-248

2024

Volltextzugriff (PDF)

Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV‐1

EMBO molecular medicine, 2016-02, Vol.8 (2), p.117-138

2016

Volltextzugriff (PDF)

The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape

Viruses, 2019-03, Vol.11 (3), p.255

2019

Volltextzugriff (PDF)

Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium

PloS one, 2017-10, Vol.12 (10), p.e0185761-e0185761

2017

Volltextzugriff (PDF)

Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium

JAMA network open, 2021-10, Vol.4 (10), p.e2128757-e2128757

2021

Volltextzugriff (PDF)

Impact of COVID-19 on the Belgian HIV epidemic: slowdown of HIV transmission and testing and adaptation of care

BMC infectious diseases, 2022-12, Vol.22 (1), p.901-901, Article 901

2022

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(79)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression

Controlling SARS-CoV-2 in schools using repetitive testing strategies

Virus-Specific T-Cell Therapy for Viral Infections of the Central Nervous System: A Review

Epigenetic control of HIV-1 post integration latency: implications for therapy

Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study

CD32+CD4+ T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency

Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies

Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017

Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections

Dynamics of Weight Change After Initiation of Contemporaneous Antiretroviral Therapy in Treatment-Naive HIV-1 Infected Patients: Results From the Belgian HIV Cohort 2015–2021

Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs

Dengue and chikungunya: future threats for Northern Europe?

Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV

Increased KL-6 levels in moderate to severe COVID-19 infection

Risk Factors for Late HIV Presentation in Patients Treated at a Single Belgian Reference Centre from 2018 to 2022

Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV‐1

The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape

Genetic Architecture of Ischaemic Strokes after COVID-19 Shows Similarities with Large Vessel Strokes

Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium

Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium

Impact of COVID-19 on the Belgian HIV epidemic: slowdown of HIV transmission and testing and adaptation of care

Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIV

Suchergebnisse filtern